Results 151 to 160 of about 49,135 (301)

Dabigatran versus warfarin in patients with atrial fibrillation.

New England Journal of Medicine, 2009
S. Connolly, M. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P. Reilly, E. Themeles, Jeanne Varrone, Susan Wang, M. Alings, D. Xavier, Jun Zhu, R. Diaz, B. Lewis, H. Darius, H. Diener, C. Joyner, L. Wallentin   +19 more
semanticscholar   +1 more source

Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study [PDF]

, 2015
BACKGROUND & AIMS: Use of dabigatran, an inhibitor of thrombin, increases the risk of gastrointestinal bleeding (GIB). However, it is not clear whether gastroprotective agents (GPAs) prevent GIB in dabigatran users.
Chan, EW, He, Y, Lau, WC, Leung, WK, Mok, MT, Tong, TS, Wong, IC   +6 more
core  

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

New England Journal of Medicine, 2017
C. Cannon, Deepak L. Bhatt, J. Oldgren, G. Lip, S. Ellis, Takeshi Kimura, M. Maeng, B. Merkely, U. Zeymer, S. Gropper, M. Nordaby, E. Kleine, Ruth Harper, Jenny Manassie, J. Januzzi, J. T. ten Berg, G. Steg, S. Hohnloser   +17 more
semanticscholar   +1 more source

Dabigatran (October 2011)

Cleveland Clinic Journal of Medicine, 2012
Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).
openaire   +2 more sources

Letter by David et al Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial” [PDF]

, 2013
Jean David, Vincent Piriou, Pierre Albaladejo   +2 more
openalex   +1 more source

Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation

, 2021
Takumi Osawa, Hitoshi Mori, Akane Kawai, Daisuke Kawano, Kenta Tsutsui, Yoshifumi Ikeda, Mitsuki Yamaga, Atsushi Sato, Youdou Gatate, Akira Hamabe, Hirotsugu Tabata, Ritsushi Kato, Kazuo Matsumoto   +12 more
openalex   +1 more source

Closure Device-Related Thrombosis After Anticoagulation With Dabigatran in Patients Undergoing Percutaneous Left Atrial Appendage Closure: Case Reports and Literature Review [PDF]

, 2020
Xiaoye Li, Qinchun Jin, Xiaochun Zhang
openalex   +1 more source

Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

New England Journal of Medicine, 2009
S. Schulman, C. Kearon, A. Kakkar, P. Mismetti, S. Schellong, H. Eriksson, David Baanstra, J. Schnee, S. Goldhaber   +8 more
semanticscholar   +1 more source

Situación actual de los nuevos anticoagulantes orales [PDF]

, 2013
For more than half a century, vitamin K antagonists have defined oral anticoagulant therapy for the long-term management of thrombotic disorders. Despite its clinical efficacy, vitamin-antagonists have multiple, well-known limitations, including numerous
Albarrán Severo, Beatriz, Andujar Troncoso, Giselle, Cidoncha Morcillo, Borja, García Frade, Luis Javier, González Mena, Beatriz   +4 more
core   +1 more source

Association of rs2244613 Polymorphism with Dabigatran Pharmacokinetics and Safety: A Systematic Review and Meta-Analysis [PDF]

, 2022
Haobo Li, Zhu Zhang, Haoyi Weng, Yuting Qiu, Pablo Zubiaur, Yu Zhang, Guohui Fan, Peiran Yang, Anna‐Leena Vuorinen, Xianbo Zuo, Zhenguo Zhai, Chen Wang   +11 more
openalex   +1 more source